Compound Detail
CHEMBL150941
Enter ChEMBL ID:
Free Research Context
This compound will appear in recent viewed items on the research home for this browser.
Research home
View demo workspace
Basic Information
| ChEMBL ID | CHEMBL150941 |
| Phase | Preclinical |
| Structure Type | MOL |
| InChI Key | SARPNWVIQRJBKS-UHFFFAOYSA-N |
1
Targets
1
Activities
1
Assay Types
0
PK Parameters
1
Publications
0
Known Names
Molecular Properties
396.4
MW (Da)
5.09
ALogP
6
HBA
0
HBD
55.4
PSA (Ų)
0.50
QED
1
Ro5 Violations
9
Rot. Bonds
Drug Information
| Molecule Type | Small molecule |
| Availability | Unknown |
| Chirality | Unknown |
Activity Summary
IC50 1 meas. best 4.29
Target Activity Profile
| Target | Type | Best pChEMBL | Mean pChEMBL | Best (nM) | # Data |
|---|---|---|---|---|---|
| K562 CHEMBL385 | IC50 | 4.29 | 4.29 | 51000.0 | 1 |
Activity Data Samples
Top measurements by pChEMBL value
| Target | Type | Rel. | Value | Units | pChEMBL | Assay | PubMed |
|---|---|---|---|---|---|---|---|
| K562 | IC50 | = | 51000.0 | nM | 4.29 | Concentration required for 50% inhibition of K562 human chronic myelogenous leuk... | 11140732 |
Literature References
| PubMed | DOI | Target Context | # Activities |
|---|---|---|---|
| 11140732 | 10.1016/s0960-894x(00)00596-5 | K562 | 1 |
Data from ChEMBL 36 via Core Engine